Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Zafgen begins phase III trial of beloranib in Prader-Willi syndrome

Oct. 2, 2014

FDA grants orphan drug status to G-Pump for prevention of chronic severe hypoglycemia

Oct. 1, 2014

Acasti Pharma reports phase II data for CaPre

Oct. 1, 2014

SostAb shows promise for fracture healing in animal models of type 1 diabetes

Sep. 30, 2014

MicroBiome's NM-505 may improve tolerability of metformin in type 2 diabetes

Sep. 30, 2014

Repros reports data from second pivotal study of Androxal for secondary hypogonadism

Sep. 30, 2014

Signifor recommended by CHMP to treat patients with acromegaly

Sep. 29, 2014

EMA committee hands down positive opinion on Trulicity

Sep. 29, 2014

EMA recommends ketoconazole for approval in Cushing's syndrome

Sep. 29, 2014

Lipocine reports topline results from phase III trial of LPCN-1021

Sep. 29, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 8, 2026.
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...